Literature DB >> 15100151

A TREM family member, TLT-1, is found exclusively in the alpha-granules of megakaryocytes and platelets.

A Valance Washington1, Rebecca L Schubert, Laura Quigley, Theresa Disipio, Robert Feltz, Edward H Cho, Daniel W McVicar.   

Abstract

The triggering receptors expressed on myeloid cells (TREMs) have drawn considerable attention due to their ability to activate multiple cell types within the innate immune system, including neutrophils, monocyte/macrophages, and dendritic cells, via their association with DAP12. TLT-1 (TREM-like transcript-1) lies within the TREM gene cluster and contains the characteristic single V-set immunoglobulin (Ig) domain of the family, but its longer cytoplasmic tail is composed of both a proline-rich region and an immune receptor tyrosine-based inhibitory motif, the latter known to be used for interactions with protein tyrosine phosphatases. Here we report that TLT-1 is expressed exclusively in platelets and megakaryocytes (MKs) and that TLT-1 expression is up-regulated dramatically upon platelet activation. Consistent with this observation, confocal microscopy demonstrates that TLT-1 is prepackaged, along with CD62P, into both MK and platelet alpha-granules. Differences in thrombin-induced redistribution of CD62P and TLT-1 indicate that TLT-1 is not simply cargo of alpha-granules but may instead regulate granule construction or dispersal. Together these data show that that TLT-1 does not function to inhibit members of the TREM family but instead may play a role in maintaining vascular hemostasis and regulating coagulation and inflammation at sites of injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100151     DOI: 10.1182/blood-2004-01-0315

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  42 in total

Review 1.  Triggering receptor expressed on myeloid cells receptor family modulators: a patent review.

Authors:  Christopher J Pelham; Amit N Pandya; Devendra K Agrawal
Journal:  Expert Opin Ther Pat       Date:  2014-11-01       Impact factor: 6.674

2.  Proteomic analysis of palmitoylated platelet proteins.

Authors:  Louisa Dowal; Wei Yang; Michael R Freeman; Hanno Steen; Robert Flaumenhaft
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

3.  TREM-like transcript 1: a more sensitive marker of platelet activation than P-selectin in humans and mice.

Authors:  Christopher W Smith; Zaher Raslan; Lola Parfitt; Abdullah O Khan; Pushpa Patel; Yotis A Senis; Alexandra Mazharian
Journal:  Blood Adv       Date:  2018-08-28

Review 4.  Platelet receptor signaling in thrombus formation.

Authors:  David Stegner; Bernhard Nieswandt
Journal:  J Mol Med (Berl)       Date:  2010-11-07       Impact factor: 4.599

5.  Levels of soluble TREM-like transcript 1 in patients presenting to the emergency department with chest pain.

Authors:  Omar L Esponda; Robert Hunter; José R Rivera Del Río; A Valance Washington
Journal:  Clin Appl Thromb Hemost       Date:  2014-08-21       Impact factor: 2.389

Review 6.  TREM and TREM-like receptors in inflammation and disease.

Authors:  Jill W Ford; Daniel W McVicar
Journal:  Curr Opin Immunol       Date:  2009-02-21       Impact factor: 7.486

7.  Soluble TLT-1 modulates platelet-endothelial cell interactions and actin polymerization.

Authors:  Jessica Morales; Karina Villa; Jim Gattis; William Castro; Katiria Colon; Jacek Lubkowski; Priscilla Sanabria; Robert Hunter; A Valance Washington
Journal:  Blood Coagul Fibrinolysis       Date:  2010-04       Impact factor: 1.276

8.  CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo.

Authors:  Musaed M Alshahrani; Eunice Yang; Jana Yip; Simona S Ghanem; Simon L Abdallah; Anthony M deAngelis; Cindy J O'Malley; Fatemeh Moheimani; Sonia M Najjar; Denise E Jackson
Journal:  Blood       Date:  2014-08-01       Impact factor: 22.113

9.  Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.

Authors:  Shinobu Matsuura; Yukiko Komeno; Kristen E Stevenson; Joseph R Biggs; Kentson Lam; Tingdong Tang; Miao-Chia Lo; Xiuli Cong; Ming Yan; Donna S Neuberg; Dong-Er Zhang
Journal:  Blood       Date:  2012-08-23       Impact factor: 22.113

10.  G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2.

Authors:  Jun Mori; Andrew C Pearce; Jennifer C Spalton; Beata Grygielska; Johannes A Eble; Michael G Tomlinson; Yotis A Senis; Steve P Watson
Journal:  J Biol Chem       Date:  2008-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.